Intranasal delivery of DNA encoding antigens of Mycobacterium tuberculosis by non-pathogenic invasive Escherichia coli

Vaccine

Volumn 26, Issue 16, 2008, Pages 1934-1941

  Brun, Paola ^a   Zumbo, Antonella ^b   Castagliuolo, Ignazio ^a   Delogu, Giovanni ^b   Manfrin, Filippo ^a   Sali, Michela ^b   Fadda, Giovanni ^b   Grillot Courvalin, Catherine ^c   Palù, Giorgio ^a   Manganelli, Riccardo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b CATHOLIC UNIVERSITY   (Italy)

^c INSTITUT PASTEUR   (France)

Author keywords

Delivery system; DNA vaccine; Live recombinant vaccine; Mycobacterium tuberculosis; Tuberculosis

Indexed keywords

BACTERIAL PROTEIN; BCG VACCINE; DNA VACCINE; PROTEIN FBPA; PROTEIN HTPX; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BAGG ALBINO MOUSE; CELL CULTURE; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE MODEL; DNA MODIFICATION; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; ESCHERICHIA COLI; GENE AMPLIFICATION; INFECTION PREVENTION; MALE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE;

ACYLTRANSFERASES; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; CELLS, CULTURED; CYTOKINES; ESCHERICHIA COLI; FEMALE; HEAT-SHOCK PROTEINS; IMMUNIZATION SCHEDULE; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MYCOBACTERIUM TUBERCULOSIS; SPLEEN; T-LYMPHOCYTES; TUBERCULOSIS; TUBERCULOSIS VACCINES; VACCINATION; VACCINES, DNA;

EID: 40849101451     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.02.023     Document Type: Article

References (32)

1. Sizemore D.R., Branstrom A.A., and Sadoff J.C. Attenuated bacteria as a DNA delivery vehicle for DNA-mediated immunization. Vaccine 15 8 (1997) 804-807
2. Chou C.K., Hung J.Y., Liu J.C., Chen C.T., and Hung M.C. An attenuated Salmonella oral DNA vaccine prevents the growth of hepatocellular carcinoma and colon cancer that express alpha-fetoprotein. Cancer Gene Ther (2006)
3. Parida S.K., Huygen K., Ryffel B., and Chakraborty T. Novel bacterial delivery system with attenuated Salmonella typhimurium carrying plasmid encoding Mtb antigen 85A for mucosal immunization: establishment of proof of principle in TB mouse model. Ann NY Acad Sci 1056 (2005) 366-378
4. Bauer H., Darji A., Chakraborty T., and Weiss S. Salmonella-mediated oral DNA vaccination using stabilized eukaryotic expression plasmids. Gene Ther 12 4 (2005) 364-372
5. Vecino W.H., Quanquin N.M., Martinez-Sobrido L., Fernandez-Sesma A., Garcia-Sastre A., Jacobs Jr. W.R., et al. Mucosal immunization with attenuated Shigella flexneri harboring an influenza hemagglutinin DNA vaccine protects mice against a lethal influenza challenge. Virology 325 2 (2004) 192-199
6. Vassaux G., Nitcheu J., Jezzard S., and Lemoine N.R. Bacterial gene therapy strategies. J Pathol 208 2 (2006) 290-298
7. Castagliuolo I., Beggiao E., Brun P., Barzon L., Goussard S., Manganelli R., et al. Engineered E. coli delivers therapeutic genes to the colonic mucosa. Gene Ther 12 13 (2005) 1070-1078
8. Critchley R.J., Jezzard S., Radford K.J., Goussard S., Lemoine N.R., Grillot-Courvalin C., et al. Potential therapeutic applications of recombinant, invasive E. coli. Gene Ther 11 15 (2004) 1224-1233
9. Fajac I., Grosse S., Collombet J.M., Thevenot G., Goussard S., Danel C., et al. Recombinant Escherichia coli as a gene delivery vector into airway epithelial cells. J Control Release 97 2 (2004) 371-381
10. Grassl G.A., Bohn E., Muller Y., Buhler O.T., and Autenrieth I.B. Interaction of Yersinia enterocolitica with epithelial cells: invasin beyond invasion. Int J Med Microbiol 293 1 (2003) 41-54
11. Grillot-Courvalin C., Goussard S., Huetz F., Ojcius D.M., and Courvalin P. Functional gene transfer from intracellular bacteria to mammalian cells. Nat Biotechnol 16 9 (1998) 862-866
12. Raviglione M.C. The TB epidemic from 1992 to 2002. Tuberculosis (Edinb) 83 1-3 (2003) 4-14
13. Kaufmann S.H. Introduction. Rational vaccine development against tuberculosis: "Those who don't remember the past are condemned to repeat it". Microbes Infect (2005)
14. Huygen K. Plasmid DNA vaccination. Microbes Infect 7 5-6 (2005) 932-938
15. Kaufmann S.H., Cole S.T., Mizrahi V., Rubin E., and Nathan C. Mycobacterium tuberculosis and the host response. J Exp Med 201 11 (2005) 1693-1697
16. Lozes E., Huygen K., Content J., Denis O., Montgomery D.L., Yawman A.M., et al. Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex. Vaccine 15 8 (1997) 830-833
17. Baldwin S.L., D'Souza C., Roberts A.D., Kelly B.P., Frank A.A., Lui M.A., et al. Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis. Infect Immun 66 6 (1998) 2951-2959
18. Tanghe A., Denis O., Lambrecht B., Motte V., van den Berg T., and Huygen K. Tuberculosis DNA vaccine encoding Ag85A is immunogenic and protective when administered by intramuscular needle injection but not by epidermal gene gun bombardment. Infect Immun 68 7 (2000) 3854-3860
19. Delogu G., Li A., Repique C., Collins F., and Morris S.L. DNA vaccine combinations expressing either tissue plasminogen activator signal sequence fusion proteins or ubiquitin-conjugated antigens induce sustained protective immunity in a mouse model of pulmonary tuberculosis. Infect Immun 70 1 (2002) 292-302
20. Skeiky Y.A., Alderson M.R., Ovendale P.J., Guderian J.A., Brandt L., Dillon D.C., et al. Differential immune responses and protective efficacy induced by components of a tuberculosis polyprotein vaccine, Mtb72F, delivered as naked DNA or recombinant protein. J Immunol 172 12 (2004) 7618-7628
21. Mustafa A.S. Development of new vaccines and diagnostic reagents against tuberculosis. Mol Immunol 39 1-2 (2002) 113-119
22. Manganelli R., Voskuil M.I., Schoolnik G.K., Dubnau E., Gomez M., and Smith I. Role of the extracytoplasmic-function Sigma Factor SigH in Mycobacterium tuberculosis global gene expression. Mol Microbiol 45 2 (2002) 365-374
23. Graham J.E., and Clark-Curtiss J.E. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci U.S.A. 96 20 (1999) 11554-11559
24. Kaushal D., Schroeder B.G., Tyagi S., Yoshimatsu T., Scott C., Ko C., et al. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc Natl Acad Sci U.S.A. 99 12 (2002) 8330-8335
25. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 6685 (1998) 537-544
26. Li Z., Howard A., Kelley C., Delogu G., Collins F., and Morris S. Immunogenicity of DNA vaccines expressing tuberculosis proteins fused to tissue plasminogen activator signal sequences. Infect Immun 67 9 (1999) 4780-4786
27. Andersen P. Tuberculosis vaccines-an update. Nat Rev Microbiol 5 7 (2007) 484-487
28. Collins F.M. Protection to mice afforded by BCG vaccines against an aerogenic challenge by three mycobacteria of decreasing virulence. Tubercle 66 4 (1985) 267-276
29. Orme I.M. The mouse as a useful model of tuberculosis. Tuberculosis (Edinb) 83 1-3 (2003) 112-115
30. Kirman J.R., Turon T., Su H., Li A., Kraus C., Polo J.M., et al. Enhanced immunogenicity to Mycobacterium tuberculosis by vaccination with an alphavirus plasmid replicon expressing antigen 85A. Infect Immun 71 1 (2003) 575-579
31. Brandt L., Elhay M., Rosenkrands I., Lindblad E.B., and Andersen P. ESAT-6 subunit vaccination against Mycobacterium tuberculosis. Infect Immun 68 2 (2000) 791-795
32. Dietrich J., Lundberg C.V., and Andersen P. TB vaccine strategies-what is needed to solve a complex problem?. Tuberculosis (Edinb) 86 3-4 (2006) 163-168